| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06955260 | SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure | Congenital Heart Disease | Recruiting | 2026-09-02 |
| NCT07655362 | Baxdrostat and Ventricular Remodeling | Cardiac Remodeling | Not Yet Recruiting | 2026-06-17 |
| NCT07270367 | Finerenone and Cardiac Remodeling | Heart Failure | Not Yet Recruiting | 2025-12-08 |
Heart Disease (2) · Heart Failure (1)